Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Sunitinib Treatment Exacerbates intratumoral Heterogeneity in Metastatic Renal Cancer
QMRO Home
Barts Cancer Institute
Centre for Experimental Cancer Medicine
Sunitinib Treatment Exacerbates intratumoral Heterogeneity in Metastatic Renal Cancer
QMRO Home
Barts Cancer Institute
Centre for Experimental Cancer Medicine
Sunitinib Treatment Exacerbates intratumoral Heterogeneity in Metastatic Renal Cancer
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors
Sunitinib Treatment Exacerbates intratumoral Heterogeneity in Metastatic Renal Cancer
Volume
21
Pagination
4212 - 4223
DOI
10.1158/1078-0432.CCR-15-0207
Journal
CLINICAL CANCER RESEARCH
Issue
18
ISSN
1078-0432
Metadata
Show full item record
Authors
Stewart, GD; O'Mahony, FC; Laird, A; Eory, L; Lubbock, ALR; Mackay, A; Nanda, J; O'Donnell, M; Mullen, P; McNeill, SA
URI
http://qmro.qmul.ac.uk/xmlui/handle/123456789/11015
Collections
Centre for Experimental Cancer Medicine
[130]
Licence information
• “The final publication is available at http://clincancerres.aacrjournals.org/content/21/18/4212.long”